| 000 | 01325 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515055720.0 | ||
| 264 | 0 | _c20070604 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2404591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInami, M | |
| 245 | 0 | 0 |
_aPolycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia. _h[electronic resource] |
| 260 |
_bLeukemia _cMay 2007 |
||
| 300 |
_a1103-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPolycythemia _xetiology |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 700 | 1 | _aInokuchi, K | |
| 700 | 1 | _aOkabe, M | |
| 700 | 1 | _aKosaka, F | |
| 700 | 1 | _aMitamura, Y | |
| 700 | 1 | _aYamaguchi, H | |
| 700 | 1 | _aDan, K | |
| 773 | 0 |
_tLeukemia _gvol. 21 _gno. 5 _gp. 1103-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2404591 _zAvailable from publisher's website |
| 999 |
_c16861152 _d16861152 |
||